Melanotan II: A Non-Selective Melanocortin Agonist — Research Overview
Melanotan II: A Non-Selective Melanocortin Agonist — Research Overview
Melanotan II (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH) with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂. It was developed at the University of Arizona by Dr. Victor Hruby and Dr. Mac Hadley in the 1980s through structure-activity relationship studies on the melanocortin peptide family (Hadley & Dorr, Peptides, 2006; PMID: 16289474). Unlike its derivative PT-141, Melanotan II is a non-selective melanocortin receptor agonist — meaning it demonstrates significant activity across multiple melanocortin receptor subtypes, including MC1R, MC3R, MC4R, and MC5R.
Mechanism of Action
Melanotan II's mechanism of action involves simultaneous agonism at multiple melanocortin receptors, each mediating different physiological functions:
MC1R and melanogenesis: MC1R is the melanocortin receptor expressed on melanocytes — the pigment-producing cells in the skin. Activation of MC1R by Melanotan II triggers the cAMP/PKA signaling cascade, which upregulates the enzyme tyrosinase and shifts melanin production from pheomelanin (red/yellow pigment) toward eumelanin (brown/black pigment). This process, known as melanogenesis, has been the primary area of investigation for Melanotan II (Hruby et al., Journal of Medicinal Chemistry, 1995; PMID: 7636870).
MC3R and MC4R: Through its activity at MC3R and MC4R, Melanotan II also influences central melanocortin pathways involved in energy homeostasis, autonomic regulation, and neuroendocrine function — the same pathways targeted more selectively by PT-141.
MC5R: Melanotan II also has activity at MC5R, which is expressed in sebaceous glands and exocrine tissues. The physiological significance of MC5R activation by melanocortin analogs remains an area of active investigation.
Published Research
Melanogenesis studies: The foundational research by Hruby and Hadley at the University of Arizona demonstrated that Melanotan II was approximately 1,000-fold more potent than α-MSH at stimulating melanogenesis in cell-based assays. The cyclic structure and D-Phe substitution were critical for this enhanced potency and selectivity (Hruby et al., Journal of Medicinal Chemistry, 1995; PMID: 7636870).
Structure-activity relationships: Extensive medicinal chemistry research on Melanotan II and related analogs established the structural requirements for melanocortin receptor binding and subtype selectivity. This work led to the development of more selective analogs, including PT-141 (MC4R-selective) and SHU-9119 (an MC3R/MC4R antagonist), demonstrating how systematic modification of the MT-II scaffold could shift receptor selectivity (Hadley & Dorr, Peptides, 2006; PMID: 16289474).
Photoprotection research: In preclinical models, the eumelanin produced in response to melanocortin stimulation has been studied for its UV-absorbing and free radical-scavenging properties. Eumelanin provides greater photoprotection than pheomelanin, and researchers have investigated whether melanocortin-stimulated melanogenesis could serve as a model for understanding natural UV defense mechanisms (Abdel-Malek et al., Photochemistry and Photobiology, 2006; PMID: 16613484).
Receptor pharmacology: Competitive binding assays have characterized Melanotan II's affinity at each melanocortin receptor subtype, establishing it as a valuable pharmacological tool for studying the melanocortin system. Its non-selective profile makes it useful for broad melanocortin pathway activation in research models, while more selective analogs are used to dissect individual receptor contributions.
Purity and Quality Considerations
Like PT-141, Melanotan II is a cyclic peptide with a lactam bridge requiring specialized synthesis. Researchers should verify complete cyclization, confirm purity ≥98% by HPLC, and validate molecular weight via mass spectrometry. The presence of both D-Phe and norleucine (Nle) should be documented in the supplier's analytical data. Learn more about peptide purity testing and how to read a COA.
Available for Research
CALM Peptides offers research-grade Melanotan 2 with third-party purity verification. Certificates of Analysis are available upon request. Browse all skin peptides or explore our full catalog.
Frequently Asked Questions
What is Melanotan II?
Melanotan II is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH). Developed at the University of Arizona, it is a non-selective melanocortin receptor agonist studied primarily for its potent activation of MC1R-mediated melanogenesis.
How does Melanotan II relate to PT-141?
PT-141 was originally identified as a metabolite of Melanotan II. While MT-II activates multiple melanocortin receptors (MC1R, MC3R, MC4R, MC5R), PT-141 has a more selective profile focused on MC4R/MC3R with reduced MC1R activity.
What is melanogenesis?
Melanogenesis is the biological process of melanin production in melanocytes. Melanocortin receptor activation shifts production from pheomelanin (red/yellow) toward eumelanin (brown/black), which has greater UV-absorbing and antioxidant properties.
Why is Melanotan II used as a research tool?
Its non-selective activity across multiple melanocortin receptor subtypes makes Melanotan II a valuable pharmacological tool for studying the melanocortin system broadly. More selective derivatives (like PT-141) are used when researchers need to isolate the effects of specific receptor subtypes.
The information presented in this article is for educational and informational purposes only and is not intended as medical advice. Melanotan II is sold as a research chemical for laboratory use only. It is not intended for human consumption, and should not be used to diagnose, treat, cure, or prevent any disease. All references to published research are provided for informational context. Consult qualified professionals for guidance related to any health condition.
For research use only. Not for human consumption.
Related Reading: What Are Peptides? · Skin Peptides · PT-141 Research Overview · GHK-Cu Research Overview · Quality & Purity Standards
The information presented in this article is for educational and informational purposes only and is not intended as medical advice. All products referenced are sold as research chemicals for laboratory use only. They are not intended for human consumption and should not be used to diagnose, treat, cure, or prevent any disease. All references to published research are provided for informational context. Consult qualified professionals for guidance related to any health condition.